share_log

Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results

SEC ·  Aug 12 18:42
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.